Want to see IN:SURAKSHA full AI Analyst Report?

Suraksha Diagnostic Ltd. (SURAKSHA) Price & Analysis

2 Followers

SURAKSHA Stock Chart & Stats

₹317.60

-₹13.40(-3.48%)

At close: Jan 08 4:00 PM EST

₹317.60

-₹13.40(-3.48%)

Day’s Range― - ―

52-Week Range₹224.10 - ₹359.00

Previous CloseN/A

Volume140.52K

Average Volume (3M)13.07K

Market Cap

₹17.50B

Enterprise Value₹12.90K

Total Cash (Recent Filing)₹263.48M

Total Debt (Recent Filing)₹1.30B

Price to Earnings (P/E)50.7

Beta1.01

Next Earnings

Nov 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.28%

Share Statistics

EPS (TTM)6.18

Shares Outstanding52,080,757

10 Day Avg. Volume3,506

30 Day Avg. Volume13,073

Financial Highlights & Ratios

PEG Ratio32.20

Price to Book (P/B)4.85

Price to Sales (P/S)3.82

P/FCF Ratio70.61

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)8.65

Revenue Forecast (FY)₹3.68B

Bulls Say, Bears Say

Bulls Say

Sustained Revenue GrowthSeveral years of solid revenue growth indicate expanding diagnostic demand and improving business scale rather than a single-period recovery. Continued top-line expansion can support greater laboratory and imaging utilization, reinforce the company’s market presence, and provide a durable base for earnings growth.

Healthy Operating ProfitabilityHealthy operating and EBITDA margins show that the diagnostic network is generating meaningful profit from its service revenue. This profitability provides capacity to reinvest in testing and imaging capabilities, absorb moderate cost pressure, and preserve competitive strength over the next several quarters.

Strong Operating Cash GenerationOperating cash flow exceeding accounting profit supports the quality of reported earnings and demonstrates that core diagnostic operations generate cash. This internally generated funding can help support routine investment and business needs, even though free-cash-flow conversion remains less consistent.

Bears Say

Margin VolatilityThe sharp decline in gross margin and lower net margin indicate that profitability has not been consistently sustained despite revenue growth. Possible pricing, cost, or mix effects could continue to pressure earnings, reducing the benefit of scale and making future profit progression less predictable.

Rising Leverage And Lower ReturnsIncreasing leverage alongside weaker return on equity reduces the strength of the balance-sheet profile. Higher debt can constrain financial flexibility and increase the funding burden, while declining returns suggest that additional capital is currently producing less shareholder profitability than in the prior year.

Weak Free-Cash-Flow ConversionLow free-cash-flow conversion means reported profits are not translating consistently into cash available after investment. The gap may limit internally funded expansion and shareholder returns, while the choppy multi-year trajectory makes cash generation less dependable for capital allocation and debt management.

Suraksha Diagnostic Ltd. News

Suraksha Diagnostic’s Company Secretary and Compliance Officer Resigns

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) has issued an update. Suraksha Diagnostic Limited has announced that Ms. Mamta...

4M ago

Suraksha Diagnostic Closes Trading Window Ahead of FY26 Results

An announcement from Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) is now available. Suraksha Diagnostic Limited has notified the...

6M ago

Suraksha Diagnostic CFO K S Ravindra to Step Down by May 31, 2026

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) has issued an update. Suraksha Diagnostic Limited has announced that Group Chief...

7M ago

Suraksha Diagnostic Announces Trading Window Closure

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) just unveiled an announcement. Suraksha Diagnostic Limited has announced the closure of...

1y ago

Suraksha Diagnostic to Present Q1 Financial Results in Upcoming Earnings Call

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) has provided an update. Suraksha Diagnostic Limited announced an upcoming Investor Presentation...

1y ago

Suraksha Diagnostic Ltd. Releases Unaudited Financial Results

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) just unveiled an update. Suraksha Diagnostic Ltd. has published its unaudited financial...

2y ago

SURAKSHA FAQ

What was Suraksha Diagnostic Ltd.’s price range in the past 12 months?

Suraksha Diagnostic Ltd. lowest stock price was ₹224.10 and its highest was ₹359.00 in the past 12 months.

What is Suraksha Diagnostic Ltd.’s market cap?

Suraksha Diagnostic Ltd.’s market cap is ₹17.50B.

When is Suraksha Diagnostic Ltd.’s upcoming earnings report date?

Suraksha Diagnostic Ltd.’s upcoming earnings report date is Nov 14, 2026 which is in 52 days.

How were Suraksha Diagnostic Ltd.’s earnings last quarter?

Suraksha Diagnostic Ltd. released its earnings results on Aug 12, 2026. The company reported ₹2.5 earnings per share for the quarter.

Is Suraksha Diagnostic Ltd. overvalued?

According to Wall Street analysts Suraksha Diagnostic Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Suraksha Diagnostic Ltd. pay dividends?

Suraksha Diagnostic Ltd. pays a Monthly dividend of ₹0.5 which represents an annual dividend yield of 0.28%. See more information on Suraksha Diagnostic Ltd. dividends here

What is Suraksha Diagnostic Ltd.’s EPS estimate?

Suraksha Diagnostic Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Suraksha Diagnostic Ltd. have?

Suraksha Diagnostic Ltd. has 52,080,757 shares outstanding.

What happened to Suraksha Diagnostic Ltd.’s price movement after its last earnings report?

Suraksha Diagnostic Ltd. reported an EPS of ₹2.5 in its last earnings report. Following the earnings report the stock price went up 4.805%.

Which hedge fund is a major shareholder of Suraksha Diagnostic Ltd.?

Currently, no hedge funds are holding shares in IN:SURAKSHA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suraksha Diagnostic Ltd.

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.